Market expansion in med derm cross over: Almirall’s Seysara (sarecycline) won NMPA approval for moderate to severe acne (≥9 years), with China commercial launch targeted for 2026 – relevant to ...
ZS tops Q2 estimates with 26% revenue growth and strong customer momentum, prompting the company to lift its full-year ...
Chemical biomarkers are measurable molecular signatures (host immune markers, pathogen metabolites, volatile organic ...
With 5 open applications and claims already applicable to AI and data lakes, acquiring this portfolio now would be a ...
Entrada Therapeutics, Inc. (Nasdaq: TRDA) today reported financial results for the fourth quarter and full year ended December 31, 2025, and highlighted recent business updates. “We have started 2026 ...
Cemsidomide Advancing into Later-stage Development with Potential for Accelerated Approval; First Patient Dosed in the Phase 2 MOMENTUM Trial for ...
Andrew Siciliano deep dives on the 2026 NFL Draft with Nate Tice & ESPN’s Matt Miller.
NDA for rusfertide submitted to the US Food and Drug Administration (FDA), with potential approval and launch this ...
Through Artivism and Science, Social Art and Culture, and Whitman-Walker Health are Delivering Change “The opportunity ...
The leading enterprise security platform strengthens defences against today’s cyber threats while preparing customers ...
“L. Ron Hubbard Presents Writers of the Future Volume 42” will celebrate a milestone of over 1,000 writers and illustrators published in the series.
Experienced kids advertising executive strengthens direct-to-brand strategy as Company provides business update ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results